Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment
|Study Design:||Observational Model: Case-Only
Time Perspective: Retrospective
|Official Title:||Delayed Puberty in Boys; Clinical and Biochemical Characteristics and Effect of Testosterone Treatment - Retrospective Experience From a Single Tertiary Referral Centre 1990-2013|
- Age at diagnosis in boys with delayed puberty. [ Time Frame: At first evaluation ]We will evaluate the mean age at diagnosis as well as the age distribution of newly diagnosed boys. These data are compared to age at onset and progression of normal puberty in contemporary healthy Danish boys.
- Selected secondary outcomes include clinical, auxological and biochemical parameters and association to specific genetic polymorphisms [ Time Frame: At first evaluation and during first 12 months of observation / treatment ]Specifically, genital stage, pubic hair stage, axillary hair, axillary sweat, gynecomastia, micropenis, height, mother height, father height, target height, weight, BMI, bone age and predicted adult height. We will evaluate serum levels of follicle stimulating hormone, luteinizing hormone, estradiol, anti-mullerian hormone, sex hormone-binding globulin, testosterone, dehydroepiandrosterone-sulfate, androstenedione, inhibin A, inhibin B, growth hormone, insulin like growth factor-1 and insulin like growth factor binding protein-3. We will evaluate the effect of candidate polymorphisms suspected to affect pubertal timing, e.g. FSHR, FSHB, FGF23, KISS1, NeurokininB, GnRH, GnRH-R, LH, LH-R, GHRd3.
Biospecimen Retention: Samples With DNA
|Study Start Date:||January 1990|
|Study Completion Date:||October 2013|
|Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|
Boys with delayed puberty
Boys with no signs of puberty by an age that is -2 standard deviation below the population mean.
|Other: retrospective data collection|
Delayed Puberty in Boys; Clinical and biochemical characteristics and effect of testosterone treatment, is a retrospective study in a large case series of Danish boys with delayed puberty.
All boys were referred to the Department of Growth and Reproduction to be evaluated for delayed puberty.
Medical history: Birth length, birth weight, gestational age at birth, medical history (including cryptorchidism and hypospadias), family history of delayed puberty in mother, father and possible siblings.
Physical examination: Pubertal staging according to Tanners classification of boys, genitalia development (G1-G5), pubic hair development (PH1-PH6), axillary hair (yes/no), axillary sweat (yes/no), gynecomastia (yes/no), micropenis (yes/no), height, mother height, father height, target height, weight, BMI, bone age and predicted adult height.
Blood sampling for measurement of hormone levels: Follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol, anti-mullerian hormone, sex hormone-binding globulin, testosterone, dehydroepiandrosterone-sulfate, androstenedione, inhibin A, inhibin B, growth hormone, insulin like growth factor-1 and insulin like growth factor binding protein-3.
Gonadotropin-releasing hormone stimulation test for measurement of peak FSH and peak LH.
Retrospective DNA analysis looking for common polymorphisms.
If testosterone treatment were initiated, route of administration, dose and duration of treatment were registered.
Please refer to this study by its ClinicalTrials.gov identifier: NCT02034487
|Department of Growth and Reproduction, Rigshospitalet|
|Copenhagen, Denmark, 2100|
|Principal Investigator:||Anders Juul, PhD, DMSc||Rigshospitalet, Denmark|